HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Refractory thrombotic thrombocytopenic purpura complicated with multiple cerebral infarction].

Abstract
Neuropsychiatric symptoms comprise one of the five classic symptoms of autoimmune thrombotic thrombocytopenic purpura (aTTP). Although aTTP is typically transient, it is sometimes complicated by cerebral infarction with residual disability. This report presents the case of an 87-year-old man previously admitted to a different hospital with fever and transient consciousness loss. After receiving platelet transfusion with diagnosis of Evans syndrome, he was transferred to our hospital with worsening consciousness disturbance. He was subsequently diagnosed with aTTP with a PLASMIC score of 6 points, ADAMTS13 activity of less than 0.5%, and its inhibitor of 7.4 BU/ml. Platelet count and consciousness were rapidly improved with plasmapheresis and steroids, but motor aphasia emerged. MRI showed multiple cerebral infarctions, including a large infarction in the left frontal lobe. Thus, unfractionated heparin was administered. When his platelet count dropped once again on the 20th day, rituximab was added. The treatment eventually proved to be successful, and his aTTP remained in remission one year after the onset. Treatment for cerebral infarctions was switched to DOAC, and rehabilitation was continued. However, his ADL has not yet recovered. Advances in aTTP treatment have cured many similar cases. Thus, rituximab is now considered a treatment option for refractory cases. However, ischemic organ damage in acute phase and sequelae are observed. Therefore, early diagnosis and novel therapy are required.
AuthorsMikiya Kajita, Yoshiyuki Ogawa, Akira Matsumoto, Chiaki Naito, Masahiro Mihara, Tetsuya Ishikawa, Nobuhiko Kobayashi, Yuri Miyazawa, Takuma Ishizaki, Tatsuya Shimizu, Kazuya Sakai, Masaki Hayakawa, Masanori Matsumoto, Hiroshi Handa
Journal[Rinsho ketsueki] The Japanese journal of clinical hematology (Rinsho Ketsueki) Vol. 63 Issue 1 Pg. 55-61 ( 2022) ISSN: 0485-1439 [Print] Japan
PMID35135953 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Rituximab
  • Heparin
  • ADAMTS13 Protein
Topics
  • ADAMTS13 Protein
  • Aged, 80 and over
  • Cerebral Infarction (diagnostic imaging, drug therapy, etiology)
  • Heparin
  • Humans
  • Male
  • Plasma Exchange
  • Purpura, Thrombotic Thrombocytopenic (complications, diagnosis, drug therapy)
  • Rituximab (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: